Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

Testosterone Gel 1%

Superpotent Drug: Out of specification assay result was obtained during stability testing.

Terminated Wrong potency / content Teva Pharmaceuticals USA Inc NDC 0591-3216-17 D-1289-2022
Class II · Moderate risk

Launch Sequence Capsules

Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

Terminated Unapproved drug Loud Muscle Science D-1339-2022
Class I · High risk

Launch Sequence Aphrodisia Capsules

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Loud Muscle Science D-1338-2022
Class I · High risk

Launch Sequence Euphoria Capsules

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Loud Muscle Science D-1337-2022
Class I · High risk

Launch Sequence Capsules

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Loud Muscle Science D-1336-2022
Class II · Moderate risk

Hydrogen Peroxide Topical Solution

Labeling: Label Mix-Up-The primary label on the front of the bottles have Hydrogen Peroxide affixed to the front and back of the containers. However, the product inside the bottle is 70% Isopropyl Alcohol.

Terminated Labeling / mix-up Vi-Jon, LLC NDC 59779-871-45 D-1191-2022

Recalls by year